Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)].
Siebels M, Staehler M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT). Siebels M, et al. Among authors: heinzer h. Aktuelle Urol. 2010 Mar;41(2):122-30. doi: 10.1055/s-0029-1224676. Epub 2009 Nov 20. Aktuelle Urol. 2010. PMID: 19937556 German.
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller SC, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P, Reitz M. Atzpodien J, et al. Among authors: heinzer h. Br J Cancer. 2006 Aug 21;95(4):463-9. doi: 10.1038/sj.bjc.6603271. Epub 2006 Aug 8. Br J Cancer. 2006. PMID: 16909131 Free PMC article. Clinical Trial.
[Renal cell carcinoma--any new developments?].
Heinzer H, Huland H, Kuczyk M. Heinzer H, et al. Urologe A. 1999 Sep;38(5):423-4. doi: 10.1007/s001200050309. Urologe A. 1999. PMID: 10501699 German. No abstract available.
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.
Huland E, Burger A, Fleischer J, Fornara P, Hatzmann E, Heidenreich A, Heinzer H, Heynemann H, Hoffmann L, Hofmann R, Huland H, Kämpfer I, Kindler M, Kirchner H, Mehlhorn G, Moniak TH, Rebmann U, Roigas J, Schneider TH, Schnorr D, Schmitz HJ, Wenisch R, Varga Z, Vinke J. Huland E, et al. Among authors: heinzer h. Folia Biol (Praha). 2003;49(5):183-90. Folia Biol (Praha). 2003. PMID: 14680292 Clinical Trial.
195 results